1998
DOI: 10.1016/s0264-410x(97)00277-6
|View full text |Cite
|
Sign up to set email alerts
|

Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

5
119
2
6

Year Published

2000
2000
2023
2023

Publication Types

Select...
5
3
1

Relationship

1
8

Authors

Journals

citations
Cited by 111 publications
(132 citation statements)
references
References 15 publications
5
119
2
6
Order By: Relevance
“…In studies conducted in our laboratory we used a gene encoding for the catalytic domain of the enzyme trans-sialidase (TS). Immunization of BALB/c mice with the TS gene elicited specific antibodies and promoted T-cell activation (Costa et al 1998). The T-cell immune response was later characterized as being mediated mainly by CD4 Th1 and CD8 TC1 cells, which secreted a large amount of IFN-γ , but not IL-4 or IL-10 ( Rodrigues et al 1999).…”
Section: Trypanosoma Cruzimentioning
confidence: 99%
See 1 more Smart Citation
“…In studies conducted in our laboratory we used a gene encoding for the catalytic domain of the enzyme trans-sialidase (TS). Immunization of BALB/c mice with the TS gene elicited specific antibodies and promoted T-cell activation (Costa et al 1998). The T-cell immune response was later characterized as being mediated mainly by CD4 Th1 and CD8 TC1 cells, which secreted a large amount of IFN-γ , but not IL-4 or IL-10 ( Rodrigues et al 1999).…”
Section: Trypanosoma Cruzimentioning
confidence: 99%
“…The T-cell immune response was later characterized as being mediated mainly by CD4 Th1 and CD8 TC1 cells, which secreted a large amount of IFN-γ , but not IL-4 or IL-10 ( Rodrigues et al 1999). Upon challenge with infective T. cruzi trypomastigotes, immunized mice showed a significant reduction in parasitemia and survived acute lethal infection (Costa et al 1998).…”
Section: Trypanosoma Cruzimentioning
confidence: 99%
“…cruzi, the etiologic agent of Chagas' disease, is still a problem in South American countries, afflicting 16-18 million people and causing thousands of deaths every year. Plasmids containing parasitic genes have been successfully used to elicit protective immunity against experimental T. cruzi infection (8). In this study, we employed a plasmid (p154/13) containing a gene encoding the catalytic domain of T. cruzi transsialidase (TS).…”
mentioning
confidence: 99%
“…Although vector control programs and the application of chemotherapeutics are partial solutions to control of the infection and disease, these approaches alone are unlikely to be long-term solutions to combating Chagas' disease. Vaccination also has potential for reducing the severity of T. cruzi infection Chagas' disease (2)(3)(4). The design of appropriate vaccination strategies against T. cruzi requires the elucidation of the mechanisms for immune protection.…”
mentioning
confidence: 99%